Journal
PHARMACEUTICAL STATISTICS
Volume 13, Issue 6, Pages 388-396Publisher
WILEY
DOI: 10.1002/pst.1647
Keywords
diurnal variation; efficiency; robustness
Categories
Ask authors/readers for more resources
Baseline adjustment is an important consideration in thorough QT studies for non-antiarrhythmic drugs. For crossover studies with period-specific pre-dose baselines, we propose a by-time-point analysis of covariance model with change from pre-dose baseline as response, treatment as a fixed effect, pre-dose baseline for current treatment and pre-dose baseline averaged across treatments as covariates, and subject as a random effect. Additional factors such as period and sex should be included in the model as appropriate. Multiple pre-dose measurements can be averaged to obtain a pre-dose-averaged baseline and used in the model. We provide conditions under which the proposed model is more efficient than other models. We demonstrate the efficiency and robustness of the proposed model both analytically and through simulation studies. The advantage of the proposed model is also illustrated using the data from a real clinical trial. Copyright (c) 2014 John Wiley & Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available